Influenza A+B Test Kit

Short Description:

A rapid, one step test for the qualitative detection of Human Occult Blood in feces.

MOQ:1000 pcs


Product Detail

FAQ

Product Tags

【SUMMARY】

  Influenza (commonly known as ‘flu’) is a highly contagious, acute viral infection of the respiratory tract .It is a communicable disease easily transmitted through the coughing and sneezing of aerosolized droplets containing live virus.Influenza outbreaks occur each year during the fall and winter months. Type A viruses are typically more prevalent than type B viruses and are associated with most serious influenza epidemics, while type B infections are usually milder. The gold standard of laboratory diagnosis is 14-day cell culture with one of a variety of cell lines that can support the growth of influenza virus.Cell culture has limited clinical utility, as results are obtained too late in the clinical course for effective patient intervention. Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) is a newer method that is generally more sensitive than culture with improved detection rates over culture of 2-23%. However, RT-PCR is expensive, complex and must be performed in specialized laboratories. The Influenza A+B Rapid Test strip (Swab/Nasal Aspirate) qualitatively detects the presence of Influenza A and/or Influenza B antigen in nasal swab or throat swab or nasal aspirate specimens ,providing results within 15 minutes. The test uses antibodies specific for Influenza A and Influenza B to selectively detect Influenza A and Influenza B antigen in nasal swab, throat swab or nasal aspirate specimens.

【PRINCIPLE】

  The Influenza A+B Rapid Test Strip (Swab/Nasal Aspirate) is a qualitative, lateral flow immunoassay for the detection of Influenza A and Influenza B nucleoproteins in nasal swab, throat swab or nasal aspirate specimens. In this test, antibody specific to the Influenza A and Influenza B nucleoproteins is separately coated on the test line regions of the test strip. During testing, the extracted specimen reacts with the antibody to Influenza A and/or Influenza B that are coated onto particles. The mixture migrates up the membrane to react with the antibody to Influenza A and/or Influenza B on the membrane and generate one or two colored lines in the test regions. The presence of this colored line in either or both of the test regions indicates a positive result. To serve as a procedural control, a colored line will always appear in the control region if the test has performed properly.
5.How are rapid tests performed? Rapid tests are immunoassays that require specimens of specific types. Once collected, samples are placed in an extraction buffer or reagent and dropped in the test region to test for the presence of target object.(Some do not need buffer) 6.What does rapid testing reveal? Rapid tests tell us if a patient is actively infected. They detect the presence of target from patient specimens. Results are produced quickly, generally within 15 minutes, and can be performed near the place and time of patient care (as opposed to a separate laboratory setting). If the target object is detected, it indicates that immediate action should be taken.
Write your message here and send it to us